These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6698083)

  • 21. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of random endoscopic biopsy in the diagnosis of bladder carcinoma in situ.
    Vicente-Rodriguez J; Chéchile G; Algaba F; Amaral J
    Eur Urol; 1987; 13(3):150-2. PubMed ID: 3609088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.
    Wankowicz SAM; Werner L; Orsola A; Novak J; Bowden M; Choueiri TK; de Torres I; Morote J; Freeman GJ; Signoretti S; Bellmunt J
    J Urol; 2017 Oct; 198(4):817-823. PubMed ID: 28487100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of random mucosal biopsies in patients with bladder cancer: analysis of 117 cases].
    Gu FL
    Zhonghua Wai Ke Za Zhi; 1990 Mar; 28(3):181-3, 191. PubMed ID: 2379431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT; Sahin A; Altok M; Unlü N; Zorlu F
    J Urol; 2007 Sep; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of multiple biopsies obtained from bladder mucosa in renal pelvic and ureteral carcinoma].
    Tsujimoto Y; Hatano K; Satoh M; Takada T; Honda M; Matsumiya K; Fujioka H
    Nihon Hinyokika Gakkai Zasshi; 2007 Jan; 98(1):17-22. PubMed ID: 17302290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bladder tumors. Indications for and results of routine biopsies of the macroscopically healthy mucosa (with a study of surface antigens)].
    Boccon-Gibod L; Boccon-Gibod L; Deslignères S; Janin-Mercier A
    Ann Urol (Paris); 1986; 20(5):303-8. PubMed ID: 3777874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies on multiple mucosal biopsy in patients with bladder cancer. 1. Evaluation of the results of multiple mucosal biopsy in patients with bladder cancer and in vivo methylene blue staining].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1617-31. PubMed ID: 2435127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The practical use of tumor marker determination in bladder washing specimens. Assessing the urothelium of patients with superficial bladder cancer.
    Orihuela E; Varadachay S; Herr HW; Melamed MR; Whitmore WF
    Cancer; 1987 Sep; 60(5):1009-16. PubMed ID: 3607723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer.
    Jancke G; Damm O; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing the recurrence rate of bladder cancer.
    Loening S; Narayana A; Yoder L; Slymen D; Weinstein S; Penick G; Culp D
    J Urol; 1980 Jan; 123(1):29-31. PubMed ID: 7351716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of multiple biopsies of nontumorous bladder mucosa in patients with bladder cancer].
    Takahashi K; Sakashita S; Maru A; Koyanagi T
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):540-4. PubMed ID: 2747095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vascular endothelial growth factor in primary superficial bladder cancer.
    Chow NH; Liu HS; Chan SH; Cheng HL; Tzai TS
    Anticancer Res; 1999; 19(5C):4593-7. PubMed ID: 10650816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA-DR expression by high grade superficial bladder cancer treated with BCG.
    Prescott S; James K; Busuttil A; Hargreave TB; Chisholm GD; Smyth JF
    Br J Urol; 1989 Mar; 63(3):264-9. PubMed ID: 2522806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on multiple mucosal biopsy in patients with bladder cancer. 2. Evaluation on the relationship between the results of multiple mucosal biopsy and recurrence, and the clinical course of cases with carcinoma in situ and micro-invasion of carcinoma in situ].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1633-47. PubMed ID: 3825813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group.
    Mulders PF; Meyden AP; Doesburg WH; Oosterhof GO; Debruyne FM
    Br J Urol; 1994 Apr; 73(4):403-8. PubMed ID: 8199828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term results of intravesical bacillus Calmette-Guérin therapy for stage T1 superficial bladder cancer.
    Brake M; Loertzer H; Horsch R; Keller H
    Urology; 2000 May; 55(5):673-8. PubMed ID: 10792077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.